Ophthalmic composition for treatment of dry eye disease
US-2026091084-A1 · Apr 2, 2026 · US
This page is not indexed by search engines while we improve data quality.
Novaliq Gmbh — Human Necessities
Novaliq Gmbh holds 115 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Novaliq Gmbh |
| Technology | Human Necessities |
| Patents in slice | 115 |
| Recent patents in slice | 26 |
| First year | 2015 |
| Last year | 2026 |
Representative patents
Notable publications linking Novaliq Gmbh to Human Necessities.
Ophthalmic composition for treatment of dry eye disease
US-2026091084-A1 · Apr 2, 2026 · US
Ophthalmic composition for treatment of dry eye disease
US-2026091084-A1 · Apr 2, 2026 · US
Ophthalmic composition for treatment of dry eye disease
US-2026091084-A1 · Apr 2, 2026 · US
Ophthalmic composition for treatment of dry eye disease
US-2026091084-A1 · Apr 2, 2026 · US
Recent filings
Latest patents from Novaliq Gmbh in Human Necessities.
Ophthalmic composition for treatment of dry eye disease
US-2026091084-A1 · Apr 2, 2026 · US
Ophthalmic composition for treatment of dry eye disease
US-2026091084-A1 · Apr 2, 2026 · US
Ophthalmic composition for treatment of dry eye disease
US-2026091084-A1 · Apr 2, 2026 · US
Ophthalmic composition for treatment of dry eye disease
US-2026091084-A1 · Apr 2, 2026 · US
Ophthalmic composition for treatment of dry eye disease
US-2026091084-A1 · Apr 2, 2026 · US
Related pages
Navigate to parent entity pages.